Cervical cancer stage IA2-IB1
Conditions
Interventions
Control group:Systemic pelvic lymph node resection
Research group:Sentinel lymph node biopsy with carbon nanotracer
Sponsors
The First Affiliated Hospital of Zhengzhou University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Initially treated patients with cervical cancer stage IA2-IB1 according to the 2018 FIGO stage criteria; 2. Patients with squamous cell cervical cancer or ordinary cervical adenocarcinoma or adeno-squamous cell cervical carcinoma; 3. Preoperative imaging showed no lymph node metastasis; 4. Volunteer to participate in this experiment and sign the informed consent; 5. No reproductive need;
Exclusion criteria
Exclusion criteria: 1. History of severe disease of other organs or other malignancies; 2. Absolute contraindications of pregnancy and surgery; 3. Severe mental illness; 4. Poor compliance;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| postoperative complication; | — |
Secondary
| Measure | Time frame |
|---|---|
| 3 years progress-free survival rate;Quality of life assessment;intraoperative complication;3 years overall survival rate;Postoperative hospital stay;Postoperative drainage tube extraction time; | — |
Countries
China
Contacts
Public ContactRuixia Guo
The First Affiliated Hospital of Zhengzhou University
Outcome results
None listed